TVGN
NASDAQTevogen Bio Holdings Inc.
News25/Ratings2
News · 26 weeks41-64%
2026-04-192026-10-11
Mix2090d
- SEC Filings9(45%)
- Insider7(35%)
- Other4(20%)
Latest news
25 items- PRUPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLCWARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. ("Tevogen" or the "Company") (NASDAQ:TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ("LoI") to evaluate a potential transaction with HRK Healthcare LLC ("HRK"). If consummated, the proposed transaction could expand Tevogen’s healthcare infrastructure capabilities and support the Company’s evolution into a revenue-generating healthcare enterprise comprised of Tevogen Bio, its biopharma arm; Tevogen.
- PRTevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLCWARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. ("Tevogen" or the "Company") (NASDAQ:TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ("LoI") to evaluate a potential transaction with HRK Healthcare LLC ("HRK"). If consummated, the proposed transaction could expand Tevogen’s healthcare infrastructure capabilities and support the Company’s evolution into a revenue-generating healthcare enterprise comprised of Tevogen Bio, its biopharma arm; Tevogen.A
- SECTevogen Bio Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Tevogen Inc. (0001860871) (Filer)
- PRTevogen Regains Compliance with Nasdaq Global Market Continued Listing RequirementsWARREN, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. ("Tevogen" or the "Company") (NASDAQ:TVGN), an integrated healthcare enterprise combining biotechnology, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it received written notice from The Nasdaq Stock Market LLC ("Nasdaq")on September 29, 2026, confirming that the Company had regained compliance with the $50 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(B)(2)(A) for continued listing on The Nasdaq Global Market. As previously announced, on September 9, 2026, the Company had received writ
- INSIDERChief Executive Officer Saadi Ryan H. was granted 8,000,000 shares, increasing direct ownership by 216% to 11,705,689 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- INSIDERChief Financial Officer Desai Kirti was granted 750,000 shares, increasing direct ownership by 309% to 992,983 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- SECTevogen Bio Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Tevogen Inc. (0001860871) (Filer)
- INSIDERDirector Goh Keow Lin was granted 75,000 shares, increasing direct ownership by 154% to 123,678 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- INSIDERDirector Podlogar Susan M was granted 75,000 shares, increasing direct ownership by 154% to 123,678 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- INSIDERDirector Sordillo Victor J. was granted 75,000 shares, increasing direct ownership by 146% to 126,539 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- INSIDERDirector Feike Jeffrey L. was granted 75,000 shares, increasing direct ownership by 133% to 131,435 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- INSIDERDirector Patton Curtis L. was granted 75,000 shares, increasing direct ownership by 117% to 139,192 units (SEC Form 4)4 - Tevogen Inc. (0001860871) (Issuer)
- SECTevogen Bio Holdings Inc. filed SEC Form 8-K: Other Events8-K - Tevogen Inc. (0001860871) (Filer)
- SECTevogen Bio Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Tevogen Inc. (0001860871) (Filer)
- SECSEC Form S-8 filed by Tevogen Bio Holdings Inc.S-8 - Tevogen Inc. (0001860871) (Filer)
- SECSEC Form 10-Q filed by Tevogen Bio Holdings Inc.10-Q - Tevogen Inc. (0001860871) (Filer)
- SECSEC Form DEF 14A filed by Tevogen Bio Holdings Inc.DEF 14A - Tevogen Inc. (0001860871) (Filer)
- SECSEC Form 8-K filed by Tevogen Bio Holdings Inc.8-K - Tevogen Bio Holdings Inc. (0001860871) (Filer)
- PRTevogen Bio Holdings Inc. Becomes Tevogen Inc.WARREN, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced that it will operate under the name Tevogen Inc., following approval by its Board of Directors. The name change reflects Tevogen's ongoing evolution into a healthcare enterprise where science, technology, and patient care converge to shape the future of healthcare. The Company’s common stock and publicly traded warrants will continue to be publicly traded on Nasdaq under the ticker symbols "TVGN" and "TVGNW", respectively, with no changes to their existing CUSIP numbers. These changes will be effective July 30, 2026. "We are not simply building a biotechnology c
- SECSEC Form PRE 14A filed by Tevogen Bio Holdings Inc.PRE 14A - Tevogen Bio Holdings Inc. (0001860871) (Filer)
- PRTevogen Bio Announces 2026 Annual Meeting of StockholdersWARREN, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) announced that its 2026 Annual Meeting of Stockholders (the "Annual Meeting)" is scheduled for Monday, August 24, 2026. The Annual Meeting will be held virtually. Stockholders of record as of July 23, 2026 will be entitled to receive notice of and vote at the Annual Meeting or any adjournment thereof. Because the meeting date is more than 30 days after the one-year anniversary date of the 2025 Annual Meeting, stockholder proposals submitted pursuant to Rule 14a-8 of the Securities Exchange Act of 1934 (the "Exchange Act") for consideration at the Annual Meeting must be receive
- INSIDERDirector Sordillo Victor J. was granted 40,000 shares, increasing direct ownership by 347% to 51,539 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- INSIDERChief Executive Officer Saadi Ryan H. was granted 1,220,000 shares, increasing direct ownership by 49% to 3,705,689 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- INSIDERDirector Podlogar Susan M was granted 40,000 shares, increasing direct ownership by 461% to 48,678 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- INSIDERDirector Patton Curtis L. was granted 40,000 shares, increasing direct ownership by 165% to 64,192 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
TVGN FAQ
6 questionsWhere does TVGN stock trade?
Tevogen Bio Holdings Inc. (TVGN) is listed on NASDAQ.What sector and industry is TVGN in?
Tevogen Bio Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Tevogen Bio Holdings Inc. go public?
Tevogen Bio Holdings Inc. (TVGN) completed its IPO in 2022.What are analysts saying about TVGN?
Tevogen Bio Holdings Inc. has had 2 recent analyst actions on file. The most recent action was from D. Boral Capital: Hold on 2026-03-04. Recent price targets cluster around $1000.00.What companies are similar to TVGN?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare TVGN side-by-side with any of them on Quantisnow.How can I track TVGN on Quantisnow?
Quantisnow aggregates Tevogen Bio Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TVGN to receive live email and push alerts on every new disclosure.